17,236 Shares in Privia Health Group, Inc. (NASDAQ:PRVA) Purchased by Teacher Retirement System of Texas

Teacher Retirement System of Texas acquired a new stake in Privia Health Group, Inc. (NASDAQ:PRVA) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 17,236 shares of the company’s stock, valued at approximately $387,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Bessemer Group Inc. raised its holdings in Privia Health Group by 2,393.4% in the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company’s stock valued at $51,000 after acquiring an additional 2,178 shares during the last quarter. EverSource Wealth Advisors LLC lifted its holdings in Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after buying an additional 2,350 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Privia Health Group by 113.1% in the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock valued at $64,000 after purchasing an additional 1,521 shares in the last quarter. Financial Management Professionals Inc. raised its stake in Privia Health Group by 28.7% during the first quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company’s stock worth $76,000 after acquiring an additional 754 shares during the period. Finally, Quadrant Capital Group LLC grew its position in Privia Health Group by 11.8% in the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock worth $95,000 after purchasing an additional 511 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CFO David Mountcastle sold 3,322 shares of the business’s stock in a transaction on Monday, May 12th. The stock was sold at an average price of $24.99, for a total value of $83,016.78. Following the completion of the transaction, the chief financial officer directly owned 172,909 shares of the company’s stock, valued at approximately $4,320,995.91. The trade was a 1.89% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Parth Mehrotra sold 13,773 shares of the stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $24.99, for a total value of $344,187.27. Following the completion of the transaction, the chief executive officer directly owned 423,143 shares in the company, valued at $10,574,343.57. This represents a 3.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 45,949 shares of company stock valued at $1,100,368 in the last quarter. 10.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

PRVA has been the subject of several research analyst reports. Robert W. Baird upped their price target on shares of Privia Health Group from $24.00 to $26.00 and gave the company an “outperform” rating in a research report on Tuesday, April 15th. Barclays lifted their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “equal weight” rating in a research report on Tuesday, May 27th. Evercore ISI dropped their target price on shares of Privia Health Group from $30.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, July 9th. Needham & Company LLC reissued a “buy” rating and set a $30.00 price target on shares of Privia Health Group in a research note on Thursday, April 10th. Finally, Truist Financial upped their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company a “buy” rating in a report on Thursday, April 10th. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Privia Health Group has a consensus rating of “Buy” and an average price target of $28.38.

Privia Health Group Stock Performance

Shares of NASDAQ:PRVA opened at $20.71 on Friday. The stock has a market capitalization of $2.52 billion, a price-to-earnings ratio of 172.60, a PEG ratio of 3.29 and a beta of 0.82. The stock’s 50-day simple moving average is $22.64 and its two-hundred day simple moving average is $22.95. Privia Health Group, Inc. has a 52-week low of $16.47 and a 52-week high of $26.09.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.